Fibromyalgia Medical Evidence Under SSR 12-2p

Claimants seeking Social Security Disability Insurance (SSDI) for fibromyalgia must establish that their condition constitutes a medically determinable impairment under Social Security Ruling 12-2p (SSR 12-2p). The Social Security Administration (SSA) evaluates medical evidence under either the 1990 American College of Rheumatology tender point criteria or the 2010 preliminary diagnostic criteria based on widespread pain and systemic co-occurring symptoms.

Fibromyalgia is a chronic central pain sensitivity syndrome causing widespread musculoskeletal pain, profound fatigue, cognitive dysfunction, and sleep disturbance. Because the condition does not show up on standard X-rays or routine laboratory panels, SSA established SSR 12-2p to provide concrete diagnostic standards. Under Title II of the Social Security Act, claimants who demonstrate that their symptoms create functional deficits that prevent sustained full-time employment can qualify for monthly disability payments.

The Legal Purpose of Social Security Ruling 12-2p

Under 20 CFR 404.1521, a claimant cannot be awarded disability benefits based on subjective statements about pain, fatigue, or muscle stiffness alone. An applicant must first prove the presence of a Medically Determinable Impairment (MDI) established by objective medical signs, symptoms, and laboratory findings from an acceptable medical source under 20 CFR 404.1502, preferably a board-certified rheumatologist.

SSR 12-2p provides two separate diagnostic pathways to establish fibromyalgia as a medically determinable impairment: Section II.A, which adopts the 1990 American College of Rheumatology (ACR) criteria, and Section II.B, which adopts the 2010 ACR preliminary diagnostic criteria. Establishing an MDI under either pathway allows the claim to proceed through the sequential evaluation process.

Pathway One: The 1990 ACR Tender Point Criteria

Under Section II.A of SSR 12-2p, an adjudicator can establish fibromyalgia as an MDI if the claimant's medical file contains clinical evidence meeting three distinct criteria:

1. Widespread Musculoskeletal Pain

The claimant must have a documented history of widespread pain that has persisted for at least three continuous months. Under SSA rules, widespread pain means pain occurring in all four quadrants of the body: the right side, left side, above the waist, and below the waist. The claimant must also have axial skeletal pain involving the cervical spine, anterior chest, thoracic spine, or low back.

2. Tender Point Examination

The treating physician must document at least eleven positive tender points out of eighteen specific anatomic locations upon physical examination. The eighteen designated sites include bilateral points at the occiput, lower cervical spine, trapezius, supraspinatus, second rib, lateral epicondyle, gluteal region, greater trochanter, and knee.

The examination must follow specific clinical standards:

• Digital palpation must be performed using approximate finger pressure of 4 kilograms (about 9 pounds), sufficient to whiten the examiner's thumbnail.
• Tender points must be distributed bilaterally across both the left and right sides of the body, as well as above and below the waistline.
• Examiners should test control points, such as the mid-forehead or distal forearm, to confirm that tenderness is localized rather than generalized bodily sensitivity.

3. Exclusion of Other Diagnostic Mimics

The medical file must demonstrate that other medical conditions that could cause similar musculoskeletal pain were medically considered and excluded. Under 20 CFR 404.1513, physicians must document clinical evaluations and laboratory tests ruling out rheumatoid arthritis, systemic lupus erythematosus, polymyalgia rheumatica, thyroid dysfunction, and multiple sclerosis.

Pathway Two: The 2010 ACR Systemic Symptom Criteria

In modern clinical practice, many rheumatologists no longer perform manual tender point examinations, viewing them as outdated. Recognizing this shift in medical standards, SSA created Section II.B of SSR 12-2p, allowing claimants to establish an MDI using the 2010 ACR preliminary diagnostic criteria.

Under Section II.B, an applicant must fulfill three clinical elements:

1. Widespread Pain History

As with the 1990 pathway, the medical record must document a history of widespread pain across all four body quadrants and the axial spine lasting at least three months.

2. Repeated Manifestations of Six or More Systemic Symptoms

Rather than counting tender points, the physician must document repeated clinical manifestations of six or more fibromyalgia symptoms, signs, or co-occurring medical conditions. Adjudicators place significant weight on the primary core symptoms:

• Severe chronic fatigue.
• Significant cognitive difficulties, commonly referred to as fibro fog, involving working memory loss, impaired concentration, and slow processing speed.
• Waking unrefreshed despite long periods of sleep.
• Frequent depressive symptoms or generalized anxiety.
• Irritable bowel syndrome (IBS).

Other recognized systemic co-occurrences include chronic tension headaches, temporomandibular joint (TMJ) dysfunction, numbness or tingling in the extremities, interstitial cystitis, Raynaud's phenomenon, and persistent dizziness.

3. Differential Exclusion Testing

Under Section II.B, the medical record must continue to document negative laboratory testing and diagnostic imaging confirming that other potential causes of diffuse systemic pain have been systematically ruled out.

Comparing Tender Points and Systemic Symptom Pathways

While both pathways are legally equal under SSR 12-2p, understanding how your medical provider documents your illness is critical:

If a treating rheumatologist does not routinely perform tender point checks, the medical documentation must clearly itemize the systemic symptoms and co-morbid conditions required under the 2010 criteria.

Evaluating Medical Equivalence at Step 3

The SSA Listing of Impairments in 20 CFR Part 404, Subpart P, Appendix 1 does not contain a dedicated listing for fibromyalgia. However, under 20 CFR 404.1526, adjudicators must evaluate whether the claimant's impairment equals an existing listing.

Common listings used for medical equivalence include:

• Listing 14.09 (Inflammatory arthritis): Evaluated when severe joint tenderness, morning stiffness, and persistent peripheral inflammation limit walking or manual tasks.
• Listing 14.06 (Undifferentiated and mixed connective tissue disease): Evaluated when systemic symptoms cause multi-organ involvement and profound constitutional exhaustion.

If the claimant's documented clinical severity equals the criteria of an analogous listing, the claim is approved at Step 3 without an assessment of vocational history.

Residual Functional Capacity (RFC) for Fibromyalgia Claims

Most fibromyalgia claims are decided at Steps 4 and 5 of the sequential evaluation through a Residual Functional Capacity (RFC) assessment under 20 CFR 404.1545. The RFC outlines the maximum physical and mental demands the claimant can sustain during a regular forty-hour workweek.

Adjudicators evaluate both exertional and non-exertional limitations:

• Exertional limits: Chronic widespread pain and fatigue frequently restrict claimants to less than the full range of sedentary work under 20 CFR 404.1567, preventing prolonged standing, walking, or lifting more than ten pounds.
• Postural limits: Severe stiffness restricts repetitive stooping, crouching, crawling, and climbing ladders or stairs.
• Environmental limits: Increased pain sensitivity often requires avoiding extreme temperatures, humidity, and workplace vibration.
• Cognitive limits: Fibro fog impairs the ability to process complex instructions, sustain attention for two-hour intervals, or maintain rapid pace.
• Absenteeism and off-task time: In the national economy, employers rarely tolerate an employee being off-task for more than fifteen percent of the workday or missing more than one or two days of work per month.

When the treating rheumatologist documents that flare-ups cause excessive absenteeism and off-task time, vocational evidence under 20 CFR 404.1566 confirms disability.

Technical SSDI Requirements in 2026

Along with medical evidence, claimants must fulfill Title II technical requirements. Under 20 CFR 404.130, claimants must have earned adequate work credits, proving disability began before their Date Last Insured under 20 CFR 404.131.

Claimants must also not perform substantial gainful activity under 20 CFR 404.1574. In 2026, the monthly substantial gainful activity ceiling is $1,620 for non-blind applicants. Earnings exceeding this limit indicate substantial work capacity. Additionally, under 20 CFR 404.1509, the impairment must satisfy the statutory duration requirement, lasting or expected to last for a continuous period of at least twelve continuous months.

Gathering Persuasive Medical Documentation

To establish a successful fibromyalgia claim under SSR 12-2p, claimants should assemble a thorough clinical record:

• Treatment notes from a board-certified rheumatologist detailing longitudinal care and physical examination findings.
• Explicit documentation of either an 18-point tender point chart or a comprehensive list of at least six systemic symptoms.
• Laboratory reports confirming negative results for rheumatoid factor, antinuclear antibodies, sedimentation rates, and thyroid panels.
• Detailed progress notes describing the frequency, severity, and functional impact of pain flares.
• A functional Medical Source Statement from the treating specialist defining exact limitations in sitting, standing, walking, lifting, and unscheduled rest requirements.

Providing this comprehensive medical evidence enables SSA adjudicators to recognize fibromyalgia as a severe impairment and evaluate functional restrictions accurately.

Frequently Asked Questions

How does SSA determine if fibromyalgia is a medically determinable impairment? Under Social Security Ruling 12-2p, SSA requires evidence from an acceptable medical source satisfying either the 1990 ACR tender point criteria or the 2010 systemic symptom criteria.

Do you need an 18-point tender point examination to get SSDI for fibromyalgia? No. Claimants can alternatively qualify under the 2010 ACR criteria by proving widespread pain and repeated manifestations of six or more systemic fibromyalgia symptoms.

What tests are required to exclude other disorders under SSR 12-2p? Physicians must perform laboratory blood tests such as complete blood counts, ESR, rheumatoid factor, ANA, and thyroid panels to rule out conditions like lupus or arthritis.

This article is general information about Social Security Disability Insurance eligibility, not legal advice. Program rules, earnings limits, and evaluation standards change over time, and every situation is different. Consult a qualified representative or contact the Social Security Administration directly for guidance on your specific claim.